Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Emerging Molecular Markers in Uveal Melanoma and Implications for Treatment

Sunday, November 17, 2013 - Sunday, November 17, 2013
Philadelphia, PA

The goal is to establish a collaborative framework for future translational applications directed toward improved diagnosis, prognosis and therapy for individuals with UM. The expected outcome is to establish a set of specific research priorities for improved classification system for UM to promote stratification of patients for marker driven clinical trials in UM which will be followed-up with pilot concepts.

Dr. Magdalena Thurin (301) 496-1591

Co-funding Institute(s):
National Cancer Institute
Office of Rare Diseases Research

From the National Center for Advancing Translational Sciences

From the National Institutes of Health

Connect with ORDR

See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.